154 related articles for article (PubMed ID: 32535220)
61. Focal cortical hypermetabolism in atypical benign rolandic epilepsy.
Curnow SR; Vogrin SJ; Barton S; Bailey CA; Harvey AS
Epilepsy Res; 2020 Mar; 161():106288. PubMed ID: 32086099
[TBL] [Abstract][Full Text] [Related]
62. Intrinsic brain activity as a diagnostic biomarker in children with benign epilepsy with centrotemporal spikes.
Zhu Y; Yu Y; Shinkareva SV; Ji GJ; Wang J; Wang ZJ; Zang YF; Liao W; Tang YL
Hum Brain Mapp; 2015 Oct; 36(10):3878-89. PubMed ID: 26173095
[TBL] [Abstract][Full Text] [Related]
63. Effect of levetiracetam monotherapy on lipid profiles and thyroid hormones in children with epilepsy: A prospective study.
Attilakos A; Dinopoulos A; Tsirouda M; Paschalidou M; Prasouli A; Stamati A; Parasxou N; Garoufi A
Epilepsy Res; 2019 Sep; 155():106162. PubMed ID: 31301589
[TBL] [Abstract][Full Text] [Related]
64. Sensorimotor seizures of pediatric onset with unusual posteriorly oriented rolandic spikes.
Kakisaka Y; Nakasato N; Haginoya K; Kanno A; Tsuchiya S
Epilepsy Res; 2009 Apr; 84(2-3):153-8. PubMed ID: 19251400
[TBL] [Abstract][Full Text] [Related]
65. Benign childhood epilepsy with centro-temporal spikes (BCECTS): early onset of seizures is associated with poorer response to initial treatment.
You SJ; Kim DS; Ko TS
Epileptic Disord; 2006 Dec; 8(4):285-8. PubMed ID: 17150442
[TBL] [Abstract][Full Text] [Related]
66. Effects of Levetiracetam and Sulthiame on EEG in benign epilepsy with centrotemporal spikes: A randomized controlled trial.
Tacke M; Borggraefe I; Gerstl L; Heinen F; Vill K; Bonfert M; Bast T; ; Neubauer BA; Baumeister F; Baethmann M; Bentele K; Blank C; Blank HM; Bode H; Bosch F; Brandl U; Brockmann K; Dahlem P; Ernst JP; Feldmann E; Fiedler A; Gerigk M; Heß S; Hikel C; Hoffmann HG; Kieslich M; Klepper J; Kluger G; Koch H; Koch W; Korinthenberg R; Krois I; Kühne H; Kurlemann G; Mandl M; Mause U; Navratil P; Opp J; Penzien J; Prietsch V; Quattländer A; Rating D; Schara U; Shamdeen MG; Sprinz A; Wendker-Magrabi H; Stephani U; Muhle H; Straßburg HM; Töpke B; Trollmann R; Tuschen-Hofstätter E; Waltz S; Weber G; Wien FU; Wolff M; Polster T; Freitag H; Sönmez Ö; Reinhardt K; Traus M; Hoovey Z
Seizure; 2018 Mar; 56():115-120. PubMed ID: 29475094
[TBL] [Abstract][Full Text] [Related]
67. Reactivity of rolandic spikes.
Fonseca LC; Tedrus GM; Bastos A; Bosco A; Laloni DT
Clin Electroencephalogr; 1996 Jul; 27(3):116-20. PubMed ID: 8828974
[TBL] [Abstract][Full Text] [Related]
68. A neuropsychological assessment, using computerized battery tests (CANTAB), in children with benign rolandic epilepsy before AED therapy.
Vinţan MA; Palade S; Cristea A; Benga I; Muresanu DF
J Med Life; 2012 Feb; 5(1):114-9. PubMed ID: 22574100
[TBL] [Abstract][Full Text] [Related]
69. [Idiopathic focal epilepsies of infancy and childhood].
Ermolenko NA; Ermakov AIu; Buchneva IA; Voronkova KV; Zakharova EI
Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):17-24. PubMed ID: 22611673
[TBL] [Abstract][Full Text] [Related]
70. Effect of levetiracetam on epileptiform discharges in human neocortical slices.
Gorji A; Höhling JM; Madeja M; Straub H; Köhling R; Tuxhorn I; Ebner A; Wolf P; Panneck HW; Behne F; Lahl R; Speckmann EJ
Epilepsia; 2002 Dec; 43(12):1480-7. PubMed ID: 12460248
[TBL] [Abstract][Full Text] [Related]
71. Regional homogeneity (ReHo) changes in new onset versus chronic benign epilepsy of childhood with centrotemporal spikes (BECTS): A resting state fMRI study.
Zeng H; Ramos CG; Nair VA; Hu Y; Liao J; La C; Chen L; Gan Y; Wen F; Hermann B; Prabhakaran V
Epilepsy Res; 2015 Oct; 116():79-85. PubMed ID: 26354170
[TBL] [Abstract][Full Text] [Related]
72. The anti-ictogenic effects of levetiracetam are mirrored by interictal spiking and high-frequency oscillation changes in a model of temporal lobe epilepsy.
Lévesque M; Behr C; Avoli M
Seizure; 2015 Feb; 25():18-25. PubMed ID: 25645630
[TBL] [Abstract][Full Text] [Related]
73. Sequential analysis of fMRI images: A new approach to study human epileptic networks.
Donaire A; Falcón C; Carreno M; Bargallo N; Rumià J; Setoain J; Maestro I; Boget T; Pintor L; Agudo R; Falip M; Fernández S
Epilepsia; 2009 Dec; 50(12):2526-37. PubMed ID: 19490031
[TBL] [Abstract][Full Text] [Related]
74. Differences in levetiracetam and perampanel treatment-related irritability in patients with epilepsy.
Hasegawa N; Tohyama J
Epilepsy Behav; 2021 Mar; 116():107644. PubMed ID: 33549477
[TBL] [Abstract][Full Text] [Related]
75. EEG-fMRI study of the interictal epileptic activity in patients with partial epilepsy.
Liu Y; Yang T; Yang X; Liu I; Liao W; Lui S; Huang X; Chen H; Gong Q; Zhou D
J Neurol Sci; 2008 May; 268(1-2):117-23. PubMed ID: 18191150
[TBL] [Abstract][Full Text] [Related]
76. Changes in the Dentate Gyrus Gene Expression Profile Induced by Levetiracetam Treatment in Rats with Mesial Temporal Lobe Epilepsy.
Diaz-Villegas V; Pichardo-Macías LA; Juárez-Méndez S; Ignacio-Mejía I; Cárdenas-Rodríguez N; Vargas-Hernández MA; Mendoza-Torreblanca JG; Zamudio SR
Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338984
[TBL] [Abstract][Full Text] [Related]
77. Decreased Network Efficiency in Benign Epilepsy with Centrotemporal Spikes.
Ji GJ; Yu Y; Miao HH; Wang ZJ; Tang YL; Liao W
Radiology; 2017 Apr; 283(1):186-194. PubMed ID: 27631414
[TBL] [Abstract][Full Text] [Related]
78. Focal epileptiform spikes do not show a canonical BOLD response in patients with benign rolandic epilepsy (BECTS).
Masterton RA; Harvey AS; Archer JS; Lillywhite LM; Abbott DF; Scheffer IE; Jackson GD
Neuroimage; 2010 May; 51(1):252-60. PubMed ID: 20139011
[TBL] [Abstract][Full Text] [Related]
79. Clinical and electroencephalographic features of benign childhood epilepsy with centrotemporal spikes comorbidity with attention-deficit hyperactivity disorder in Southwest China.
Huang C; Hu W; Tan G; Xu Y; Liu L
Epilepsy Behav; 2020 Oct; 111():107240. PubMed ID: 32603807
[TBL] [Abstract][Full Text] [Related]
80. Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid.
Liguori C; Turner K; Izzi F; Assogna M; Canevini MP; Mercuri NB; Placidi F
CNS Neurosci Ther; 2019 May; 25(5):632-637. PubMed ID: 30675751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
